Clinical Roundup NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer February 06, 2026Vol.52 No.05
Clinical Roundup Neoadjuvant pembrolizumab helps shrink tumors in patients with desmoplastic melanoma February 06, 2026Vol.52 No.05
Clinical Roundup Oxybutynin reduces hot flashes during prostate cancer treatment, randomized study finds February 06, 2026Vol.52 No.05
Clinical Roundup Oral cancer pain and opioid tolerance share underlying process, study finds February 06, 2026Vol.52 No.05
Clinical Roundup Researchers build best practice framework to boost racial and cultural diversity in biospecimen research February 06, 2026Vol.52 No.05
Clinical Roundup Researchers create blueprint for designing CD8 killer T cells to kill cancer cells February 06, 2026Vol.52 No.05
Drugs & Targets FDA issues a boxed warning for capecitabine and fluorouracil on risks associated with DPD deficiency February 06, 2026Vol.52 No.05
PodcastThe Directors The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)Cancer centers fund small grants to boost morale amid low paylines January 30, 2026Vol.52 No.04By Paul Goldberg and Claire Marie Porter
Capitol Hill FY26 funding package blocked in Senate after ICE shooting of Alex PrettiNew package—likely excluding DHS—may go back to House early next week January 30, 2026Vol.52 No.04By Jacquelyn Cobb
